AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE

APDA is Committed to Reaching & Supporting More People with Parkinson’s Disease NEW YORK, NY, JUNE 24, 2024 –...see more The mission of the American Parkinson Disease Association (APDA) is to provide the support, education, and research to help everyone impacted by Parkinson’s disease (PD) live life to the fullest. To promote health equality and access […]

Read More

Understanding levodopa-induced dyskinesias: APDA-funded research published 

Congratulations to our 2020 APDA Research Grant Awardee Dr. Karen Jaunarajs for her work on understanding levodopa induced dyskinesias....see more Her study was recently published in Journal of Neuroscience. Dr. Jaunarajs works closely with Dr. David Standaert, Chairman of APDA’s Scientific Advisory Board, and the Chairman of University of Alabama at Birmingham’s Department of Neurology, which […]

Read More

How alpha-synuclein affects brain cell communication: APDA-funded research published

In a recently published study, Dr. Gary Ho, a recipient of APDA’s most prestigious George C. Cotzias grant, studied...see more the role of alpha-synuclein in the formation and recycling of synaptic vesicles, the system that allows nerves to talk to each other. Abnormally aggregated alpha-synuclein is a main component of the Lewy body which is the […]

Read More

A Tribute to Dr. Mahlon DeLong

Parkinson’s pioneer and friend Dr. Mahlon DeLong was a pioneer in the Parkinson’s disease (PD) field and a dear...see more friend and longtime partner of the American Parkinson Disease Association (APDA). He sadly passed away on May 17, 2024. In tribute to Dr. DeLong, we reflect on the remarkable life and career of a man who […]

Read More

The Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act has passed through both Houses of Congress!

Breaking news! This week, the Senate passed the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s...see more Act! Now that the bill has passed through both houses of Congress, it heads to the President’s desk where it will be signed into law!  Here is some history about the National Plan: In 2022, the […]

Read More

Could drugs like Ozempic help people with Parkinson’s disease? 

The Glucagon-like peptide-1 (GLP-1) agonist lixisenatide and its potential role in treating PD. GLP-1 agonists are molecules that are...see more approved for use to treat type 2 diabetes (you may be familiar with brand names like Ozempic and Weygovy). They act by mimicking human gut hormones or incretins to stimulate the release of insulin. Receptors for […]

Read More

Skin Biopsy Update: The latest news re: efficacy and usefulness in Parkinson’s disease diagnosis, now and in the future 

Skin Biopsy Update: The latest news re: efficacy and usefulness in Parkinson’s disease diagnosis, now and in the future ...see more A newly published study assessed the ability of a skin biopsy to diagnose Parkinson’s disease (PD) and related disorders and demonstrated that it was very accurate in distinguishing between those who had the disorders and those […]

Read More

AMERICAN PARKINSON DISEASE ASSOCIATION TO CELEBRATE THE POWER OF A SUPPORTIVE COMMUNITY DURING PARKINSON’S DISEASE AWARENESS MONTH

APDA Helps the Parkinson’s Community Live Better Together in April and Year-Round.With a PD Diagnosis Every 6 Minutes, Awareness...see more is Needed Now More than Ever. NEW YORK, NY, MARCH 12, 2024 — April is Parkinson’s Disease Awareness Month and the American Parkinson Disease Association (APDA) will commemorate the month by raising awareness of Parkinson’s disease […]

Read More